Whitsell Innovations, Inc. to Exhibit at Drug Information Association (DIA) 2014 50th Annual Meeting.

Whitsell Innovations, Inc. to Exhibit at Drug Information Association (DIA) 2014 50th Annual Meeting.

Whitsell Innovations (WI), Inc., a full-service medical and scientific writing company headquartered in Chapel Hill, NC, will be one of the exhibitors at Drug Information Association (DIA) 2014 50th Annual Meeting this year.  The DIA meeting is scheduled to be held from June 15 through June 19, 2014 in San Diego, California.

President and founder of WI Robin Whitsell, Senior Medical Writer and Consultant Ann Winter-Vann, PhD, Medical Writer and Consultant Lima Chutkan, PhD, and Business Development Associate Natalie Becker will all be in attendance at the Whitsell Innovations, Inc. booth number 920.

The team will be available to discuss WI’s medical writing experience and outsourcing best practices for pharmaceutical, biotech and device companies including the documentation required for submissions to the Food and Drug Administration (FDA) and international regulatory bodies during the pre-clinical and clinical development process.  They will also address how industry clients use medical writers to share clinical data in manuscripts, training materials, and presentations.

[quotes class=”quoteleft”]“DIA is our industry’s premier meeting,” says Ms. Whitsell. “We are thrilled to attend and interact with our clients and our new potential clients. We also value attending the educational offerings and increasing our understanding of the trends in medical writing and the life sciences industries.” [/quotes]

WI members will also be available to discuss the changing regulations regarding electronic technical document (eCTD) submissions, the trends in the writing of clinical study reports (CSRs), and the approaches to streamlining periodic adverse safety update reports (PADERs), and regulatory updates associated with the use of the period benefit-risk evaluation report (PBRER).  They will also be available to discuss cGMP regulations and rest of world filings.

DIA is a nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products.  DIA is committed to the broad dissemination of information among its members, with continuously improved professional practice as the goal.  DIA serves our members in a neutral, global environment that operates independent of the influence of any one organization or authority.